Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 370

1.

Statin myopathy: incidence, risk factors, and pathophysiology.

Sewright KA, Clarkson PM, Thompson PD.

Curr Atheroscler Rep. 2007 Nov;9(5):389-96.

PMID:
18001622
2.

Statin myopathy: an update.

Christopher-Stine L.

Curr Opin Rheumatol. 2006 Nov;18(6):647-53. Review.

PMID:
17053514
3.

Statin-associated myopathy and its exacerbation with exercise.

Meador BM, Huey KA.

Muscle Nerve. 2010 Oct;42(4):469-79. doi: 10.1002/mus.21817. Review.

PMID:
20878737
4.

Statin-induced apoptosis and skeletal myopathy.

Dirks AJ, Jones KM.

Am J Physiol Cell Physiol. 2006 Dec;291(6):C1208-12. Epub 2006 Aug 2. Review.

5.

Clinical characterization and molecular mechanisms of statin myopathy.

Toth PP, Harper CR, Jacobson TA.

Expert Rev Cardiovasc Ther. 2008 Aug;6(7):955-69. doi: 10.1586/14779072.6.7.955. Review.

PMID:
18666846
6.

Statin-induced myopathy: the two faces of Janus.

Arora R, Liebo M, Maldonado F.

J Cardiovasc Pharmacol Ther. 2006 Jun;11(2):105-12. Review.

PMID:
16891287
7.

Coenzyme Q(10) and statin myalgia: what is the evidence?

Mas E, Mori TA.

Curr Atheroscler Rep. 2010 Nov;12(6):407-13. doi: 10.1007/s11883-010-0134-3.

PMID:
20725809
8.

The broad spectrum of statin myopathy: from myalgia to rhabdomyolysis.

Harper CR, Jacobson TA.

Curr Opin Lipidol. 2007 Aug;18(4):401-8. Review.

PMID:
17620856
9.

Statin myopathy as a metabolic muscle disease.

Phillips PS, Haas RH.

Expert Rev Cardiovasc Ther. 2008 Aug;6(7):971-8. doi: 10.1586/14779072.6.7.971. Review.

PMID:
18666847
10.

Drug-induced myopathies. An overview of the possible mechanisms.

Owczarek J, Jasińska M, Orszulak-Michalak D.

Pharmacol Rep. 2005 Jan-Feb;57(1):23-34. Review.

11.

Narrative review: statin-related myopathy.

Joy TR, Hegele RA.

Ann Intern Med. 2009 Jun 16;150(12):858-68. Review.

PMID:
19528564
12.

Statin myopathy.

Radcliffe KA, Campbell WW.

Curr Neurol Neurosci Rep. 2008 Jan;8(1):66-72. Review.

PMID:
18367041
13.

The myopathy of statins.

Smogorzewski M.

J Ren Nutr. 2005 Jan;15(1):87-93. Review.

PMID:
15648014
14.

Low myopathy rates associated with statins as monotherapy or combination therapy with interacting drugs in a group model health maintenance organization.

Shanahan RL, Kerzee JA, Sandhoff BG, Carroll NM, Merenich JA.

Pharmacotherapy. 2005 Mar;25(3):345-51.

PMID:
15843281
15.

Genetic predisposition to statin myopathy.

Vladutiu GD.

Curr Opin Rheumatol. 2008 Nov;20(6):648-55. doi: 10.1097/BOR.0b013e328314b7b4. Review.

PMID:
18946323
16.

Neuromuscular complications of statins.

Ahn SC.

Phys Med Rehabil Clin N Am. 2008 Feb;19(1):47-59, vi. doi: 10.1016/j.pmr.2007.10.002. Review.

PMID:
18194749
17.

Managing statin myopathy.

Venero CV, Thompson PD.

Endocrinol Metab Clin North Am. 2009 Mar;38(1):121-36. doi: 10.1016/j.ecl.2008.11.002. Review.

PMID:
19217515
18.

Statin induced myopathy.

Frank RE Jr.

J Insur Med. 2009;41(2):132-5.

PMID:
19845216
19.

Risk for myopathy with statin therapy in high-risk patients.

Ballantyne CM, Corsini A, Davidson MH, Holdaas H, Jacobson TA, Leitersdorf E, März W, Reckless JP, Stein EA.

Arch Intern Med. 2003 Mar 10;163(5):553-64. Review.

PMID:
12622602
20.

How do you treat patients with myalgia who take statins?

Siddiqi SA, Thompson PD.

Curr Atheroscler Rep. 2009 Jan;11(1):9-14. Review.

PMID:
19080722

Supplemental Content

Support Center